Price | 1W % | 1M % | 3M % | 6M % | 1Y % | YTD % |
|---|---|---|---|---|---|---|
-- | -- | -- | -- | -- | -- | -- |
AI Generated Qualitative Analysis
Your time is precious, so save it. Use AI to get the most important information from the business.
Learn about National Health Investors, Inc.
National Health Investors, Inc. News
National Health Investors, Inc. Quantitative Score
About National Health Investors, Inc.
Incorporated in 1991, National Health Investors, Inc. (NYSE: NHI) is a real estate investment trust specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent, assisted and memory care communities, entrance-fee retirement communities, skilled nursing facilities, medical office buildings and specialty hospitals.
National Health Investors, Inc. Earnings & Revenue
What’s This Company Really Worth? Find Out Instantly.
Warren Buffett’s go-to valuation method is Discounted Cash Flow (DCF). Our tool makes it effortless — no spreadsheets, just answers in a few clicks.
National Health Investors, Inc. Financials
Table Compare
Compare NHI metrics with: | |||
|---|---|---|---|
Earnings & Growth | NHI | None | |
EPS (TTM) YoY Growth | -- | -- | |
Revenue (TTM) YoY Growth | -- | -- | |
Valuation (TTM) | NHI | None | |
Price/Earnings Ratio | -- | -- | |
Price/Sales Ratio | -- | -- | |
Profitability & Efficiency (TTM) | NHI | None | |
Net Profit Margin | -- | -- | |
Return on Equity | -- | -- | |
Financial Health (TTM) | NHI | None | |
Debt/Assets Ratio | -- | -- | |
Assets/Liabilities Ratio | -- | -- | |
National Health Investors, Inc. Income
National Health Investors, Inc. Balance Sheet
National Health Investors, Inc. Cash Flow
National Health Investors, Inc. Financials Over Time
Analysts Rating
Strong Buy
Buy
Hold
Sell
Strong Sell
Metrics Scores
| Metrics | Score |
|---|---|
| Discounted Cash Flows | Buy |
| Return on Equity | Strong Buy |
| Return on Assets | Strong Buy |
| Debt/Equity Ratio | Strong Sell |
| Price/Earnings Ratio | Sell |
| Price/Book Ratio | Strong Sell |
Price Targets
Disclaimer: This 3rd party analysis information is for reference only and does not constitute investment advice.
National Health Investors, Inc. Dividends
| Yield (TTM) | Dividend (TTM) | |
|---|---|---|
Infinity% | 3.6000 |
| Payment Date | Dividend | Frequency |
|---|---|---|
| 2025-08-01 | 0.9 | Quarterly |
| 2025-05-02 | 0.9 | Quarterly |
| 2025-01-29 | 0.9 | Quarterly |
| 2024-11-01 | 0.9 | Quarterly |
| 2024-08-02 | 0.9 | Quarterly |
Historical Market Cap
Shares Outstanding
National Health Investors, Inc. Executives
| Name | Role |
|---|---|
| Mr. D. Eric Mendelsohn | President, Chief Executive Officer & Director |
| Mr. John L. Spaid | Executive Vice President of Finance, Chief Financial Officer & Treasurer |
| Mr. Kevin Carlton Pascoe | Executive Vice President of Investments & Chief Investment Officer |
| Ms. Kristin Sallee Gaines | Senior Vice President & Chief Transaction Officer |
| Mr. David Louis Travis | Senior Vice President & Chief Accounting Officer |
| Name | Role | Gender | Date of Birth | Pay |
|---|---|---|---|---|
| Mr. D. Eric Mendelsohn | President, Chief Executive Officer & Director | Male | 1962 | 1.76M |
| Mr. John L. Spaid | Executive Vice President of Finance, Chief Financial Officer & Treasurer | Male | 1960 | 880.35K |
| Mr. Kevin Carlton Pascoe | Executive Vice President of Investments & Chief Investment Officer | Male | 1981 | 759.88K |
| Ms. Kristin Sallee Gaines | Senior Vice President & Chief Transaction Officer | Female | 1972 | 601.65K |
| Mr. David Louis Travis | Senior Vice President & Chief Accounting Officer | Male | 1975 | 600.35K |
National Health Investors, Inc. Insider Trades
| Date | 8 May |
| Name | Chapin Robert |
| Role | Director |
| Transaction | Acquired |
| Type | A-Award |
| Shares | 10000 |
| Date | 5 May |
| Name | Spaid John L |
| Role | CFO/EVP Finance |
| Transaction | Disposed |
| Type | F-InKind |
| Shares | 259 |
| Date | 5 May |
| Name | Mendelsohn D. Eric |
| Role | CEO and President |
| Transaction | Disposed |
| Type | F-InKind |
| Shares | 394 |
| Date | 26 Mar |
| Name | Chapin Robert |
| Role | Director |
| Transaction | Disposed |
| Type | |
| Shares | 0 |
| Date | 28 Mar |
| Name | ADAMS ROBERT G |
| Role | Director |
| Transaction | Acquired |
| Type | M-Exempt |
| Shares | 25000 |
| Date | Name | Role | Transaction | Type | Shares |
|---|---|---|---|---|---|
| 8 May | Chapin Robert | Director | Acquired | A-Award | 10000 |
| 5 May | Spaid John L | CFO/EVP Finance | Disposed | F-InKind | 259 |
| 5 May | Mendelsohn D. Eric | CEO and President | Disposed | F-InKind | 394 |
| 26 Mar | Chapin Robert | Director | Disposed | 0 | |
| 28 Mar | ADAMS ROBERT G | Director | Acquired | M-Exempt | 25000 |